Mucormycosis : case series on uninvited resident evil in COVID-19 patients

Mucormycosis is an aggressive opportunistic infection ascribed to the inhalation of fungal spores which, normally infect the nose and paranasal sinuses. this fulminant form commonly infects immunosuppressed human hosts, especially patients with AIDS, poorly controlled diabetes, lymphoma, leukemia, and those on long-term steroid use. the rise in patients with rhino-orbital mucormycosis associated with COVID-19 created havoc in this pandemic season. in this article, six cases of COVID-19 associated mucormycosis are reported. the timely diagnosis and appropriate management of this deadly invasive disease can help to reduce the mortality and morbidity rate. some healthy individuals too developed mucormycosis (phycomycosis, zygomycosis) even when no risk factors were identified. air conditioning can cause mucosal epithelium dryness, providing an optimal habitat for this organism to grow and multiply, thus leading to mucormycosis. the global fatality rate for mucormycosis is 46%. early diagnosis and therapy are crucial because mucormycosis has poor prognosis the diagnosis of mucormycosis depends on pathological findings, clinical features, and imaging, which plays a crucial role in defining the extent of the invasiveness.